Arylsulphatase A (ASA) activity in parkinsonism and symptomatic essential tremor

Acta Neurol Scand. 1994 Mar;89(3):171-4. doi: 10.1111/j.1600-0404.1994.tb01656.x.

Abstract

Arylsulphatase A (ASA) activity was evaluated in 47 patients with a diagnosis of parkinsonism or essential tremor. Mean ASA activity was significantly reduced compared with both a healthy control group of 71 individuals (p < 0.01) and with a group of 44 neurological patients without movement disorders (p < 0.02). Using definite clinical criteria the patients were classified as typical or atypical with respect to Parkinson's disease (PD) or essential tremor (ET). A normal ASA level was found in all the cases showing typical clinical features (PD and ET), while ASA activity was significantly lowered (p < 0.01) in 55.6% of the atypical cases (Parkinsonian syndrome or symptomatic ET). Our data support the hypothesis of a non-casual association between low ASA level and the clinical features of parkinsonism or symptomatic ET.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cerebroside-Sulfatase / metabolism*
  • Female
  • Humans
  • Leukocytes / enzymology
  • Male
  • Middle Aged
  • Parkinson Disease / enzymology*

Substances

  • Cerebroside-Sulfatase